Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v6-EN
Language French English
Date Updated 2018-07-03 2018-07-03
Drug Identification Number 02383497 02383497
Brand name MYLAN-BOSENTAN MYLAN-BOSENTAN
Common or Proper name BOSENTAN BOSENTAN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BOSENTAN BOSENTAN
Strength(s) 62.5MG 62.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 56BL 56BL
ATC code C02KX C02KX
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-09-20 2017-09-20
Estimated end date
Actual end date 2017-09-22 2017-09-22
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Discontinued in shortage ID 53603 . Last lot 3069351 Expires 31-May-19 Discontinued in shortage ID 53603 . Last lot 3069351 Expires 31-May-19
Health Canada comments